Baron, Alain D.,Fineman, Mark S.,Beeley, Nigel R. A.
申请号：
AU2013207329
公开号：
AU2013207329B2
申请日:
2013.01.05
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and/or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.
